Scott J. Charles

All filings by Scott J. Charles on record concern Aralez Pharmaceuticals Inc. In total, 7 filings cover trades dated from 5 February 2016 to 28 July 2017.

The open-market side counts 1 purchase for €119k alongside 2 sales for €18k. Taken together, the purchases exceed the sales by €101k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 option exercises. In 2017 alone, the filings show no purchases and 2 sales.

The record was last updated on 28 July 2017 with an open-market sale (€9,216) in Aralez Pharmaceuticals Inc. The clock since the last published purchase (17 May 2016) now reads 3,829 days. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.